Zdrowie i gospodarka · 02/12/2005

FDA Proposes to Remove Regulation on Group A Streptococcus Products

The FDA is proposing to remove the regulation on Group A streptococcus products due to its obsolescence and potential hindrance to vaccine development, as part of its efforts to reduce unnecessary regulations and update outdated rules.